Has Gopal Sachdeva, MD received payments from drug or device companies?

Yes. Drug and device makers reported $9,754 in general payments to Gopal Sachdeva, MD across 414 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Gopal Sachdeva, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Gopal Sachdeva, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Gopal Sachdeva, MD

Radiation Oncology · Emeryville, CANPI 1447449509

Payments from drug & device makers

$9,754in general payments, 2019–2025

Across 414 payments — averaging $23.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merck$1K
AstraZeneca$929
Novartis$629
Takeda Pharmaceuticals U.S.A., Inc.$617
Daiichi Sankyo Inc.$530
Johnson & Johnson$440
plus $6K from 54 others

What the payments were for

Food & beverage$9,56898%
Education$1862%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merck	39	$1,005
AstraZeneca(2 entities)	40	$929
Novartis	24	$629
Takeda Pharmaceuticals U.S.A., Inc.	46	$617
Daiichi Sankyo Inc.	22	$530
Johnson & Johnson(2 entities)	20	$440
Amgen	14	$366
Seagen Inc.	16	$326
Myriad Genetic Laboratories, Inc.	4	$294
Astellas Pharma US Inc	9	$266
Pfizer	11	$255
Regeneron Healthcare Solutions, Inc.	9	$247
GSK	8	$231
Bayer	15	$230
Bristol Myers Squibb	11	$210
Jazz Pharmaceuticals Inc.	6	$197
Sanofi	7	$192
Coherus Oncology, Inc.	6	$192
Incyte Corporation	7	$152
Pharmacyclics LLC, An Abbvie Company	7	$148
Progenics Pharmaceuticals, Inc.	2	$147
Tactile Systems Technology Inc	2	$137
Genentech USA, Inc.	4	$128
Taiho Oncology, Inc.	6	$124
Lilly USA, LLC	6	$120
AbbVie	5	$115
Agios Pharmaceuticals, Inc.	4	$107
Eisai Inc.	5	$107
Deciphera Pharmaceuticals Inc.	4	$100
Boehringer Ingelheim	5	$88
Sobi, Inc	3	$84
Myovant Sciences Inc.	3	$80
Springworks Therapeutics, Inc.	3	$70
AVEO Pharmaceuticals, Inc.	2	$57
Ipsen Biopharmaceuticals, Inc	2	$53
Karyopharm Therapeutics Inc.	2	$53
Puma Biotechnology, Inc.	2	$51
Exelixis Inc.	2	$50
Beone Medicines USA, Inc.	2	$48
Gilead(2 entities)	2	$44
EMD Serono, Inc.	2	$39
Kyowa Kirin, Inc.	2	$38
E.r. Squibb & Sons, L.L.C.	2	$38
Advanced Accelerator Applications	2	$29
Legend Biotech USA Inc.	1	$27
Tesaro, Inc.	1	$27
Genmab U.S., Inc.	1	$26
Morphosys, US Inc.	1	$24
Pharmacosmos Therapeutics Inc.	1	$23
Iovance Biotherapeutics, Inc.	1	$23
Beigene USA, Inc.	1	$22
Servier Pharmaceuticals LLC	1	$22
Sanofi-aventis U.S. LLC	1	$22
Apellis Pharmaceuticals, Inc.	1	$21
Sanofi US Services Inc.	1	$20
Mirati Therapeutics, Inc.	1	$20
Stemline Therapeutics Inc.	1	$20
Cardinal Health 414 LLC	1	$20
Rigel Pharmaceuticals, Inc.	1	$19
Blue Earth Diagnostics	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,754 in reported general payments places this provider in the 85th percentile of 627 radiation oncology providers in California.

See all radiation oncology providers in California →

Medicare billing

Part B allowed, 2024

$1,197,483

Medicare patients

251

Services billed

5,010

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
SsdSilver Sulfadiazine	12	$298
Tamsulosin Hcl	11	$95

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Emeryville

Loren Mellla Jolla$10M
Hyun KimDuarte$6M
Megan DalyOrange$4.5M
Percy LeeIrvine$2.4M
Felix FengSan Francisco$1.8M
Jeffrey WongDuarte$1.7M
Arta MonjazebSacramento$1.5M
Rakesh PatelLos Gatos$1.3M
Maximilian DiehnStanford$1.2M
Rizwan NuraniApple Valley$1.1M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →